Gubra Is A Preclinical Contract Research Organizationcroand Biotech Company Based In Denmarkfounded In 2008The Company Specializes In Peptide Based Drug Discoveryfocusing On Metabolic And Fibrotic Diseasesgubra Is Recognized For Its Advanced Models And Technologieswhich Facilitate Rapid Turnaround Times And High Quality Datain 2023Gubra Was Listed On Nasdaq Copenhagenhighlighting Its Growth Gubra Offers A Variety Of Preclinical Services To Support Pharmaceutical And Biotech Companies In Drug Developmentthese Services Include Expert Research Across Different Disease Areasutilizing Innovative Techniques And State Of The Art 3D Imaging Technologiesthe Company Also Serves As A Full Service Partner For Peptide Drug And Target Discoveryemploying Its Ai Assisted Platformstreamlineto Synthesize And Characterize Complex Peptides With A Strong Track Recordgubra Collaborates With Major Pharmaceutical Companiesincluding Boehringer Ingelheim And Bayerthe Company Is Committed To Sustainabilityinvesting In Green Initiativesand Has Recently Expanded Its Presence By Opening A U Soffice In Bostongubra Achieved A Notable 29Increase In Revenue From Its Cro Services In 2023
No conferences found for this company.
| Company Name | Gubra Aps |
| Country |
Denmark
|
| Address | N/A |
| Telephone | N/A |
| N/A |
